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Background: The expanding application of cardiac resynchronization (CRT) and implantable 
cardioverter-defibrillator therapy (lCD) to include patients with congenital heart disease 
requires careful evaluation of selection criteria and unconventional adaptive strategies to 
ensure clinical efficacy 
Methods: A single centre prospective analysis of adults post atrial redirection surgery 
(Mustard operation) for dextro-transposition of the great arteries (d-TGA) presenting with 
systemic right ventricular (sRV) dysfunction and at risk of sudden cardiac death (SCD). 
Results: All patients ( mean age 25 years, range 18-35) with varying functional disability 
{New York Heart Association (NYHA) II-III} receiving ICDs ± concomitant CRT were 
evaluated. Total follow-up period was 24 months. A patient individualized approach was 
used for device implantation. Endocardial, epicardial and transthoracic defibrillation 
strategies were examined in 5 consecutive cases. A hybridized form of CRT was employed in 
two patients. Only one patient demonstrated response to therapy while the other deteriorated 
during biventricular pacing (BVP). This prompted a novel approach to CRT using non-
contact mapping (NCM) and acute intra-arterial blood pressure response to guide endocardial 
sRV lead placement in a single patient. The ejection fraction increased from 23 -33% within 1 
week post procedure and clinical improvement was sustained after 6-months follow-up. 
Conclusion: Application of CRT II CD therapy to patients with sRV dysfunction requires 
individualized and adaptive strategies to overcome anatomical constraints. This study 
represents a chronological and evolutionary account of these measures. 
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1. Introduction 
1.1 History of atrial re-direction surgery 
Atrial redirection surgery, brought into common use by Mustard's modification of the 
Senning procedure, transformed the natural history of dextro-transposition of the great 
arteries (d-TGA) from a 90% one year mortality to a 90% 1 year survival(l). Although 
rendering the infant acyanotic with excellent functional capacity, the morphological right 
ventricle(sRV) is required to support the systemic circulation. The sRV faces substantial 
pressure overload resulting in a high incidence of late ventricular failure(2). This prompted 
an evolution to a more physiologically acceptable correction in the form of the arterial switch 
or Jatene operation(3). The arrhythmias and heart failure that usually manifest by the second 
decade of life in patients after atrial redirection surgery pose a challenge to management. 
1.2 Late complications of atrial redirection surgery. 
Apart from the progressive sRV dysfunction and heart failure, sinus bradycardia commonly 
arises because of surgical disruption to the sino-atrial node blood supply warranting early 
pacemaker implantation (commonly encountered in our cohort) (4). The incidence of 
tachyarrythmias, most notably atrial flutter and fibrillation, may be related to ventricular 
dysfunction or as a consequence of atrial scarring following surgery. Ventricular tachycardia 
(VT) and fibrillation (VF) have been documented on holter monitoring in various long term 
studies and the incidence of sudden cardiac death (SeD) ranges between 2-11 %(5). 
Mechanical complications include severe tricuspid regurgitation, valvar and sub-valvar 
pulmonary stenosis, intra-baffle leaks and obstruction to blood flow either at the level of the 
systemic cardiac veins or within the baffle because of stenosis or thrombosis. These cause 
haemodynamic compromise, potentially impede device implantation and may require 
preceding intervention to facilitate access ofpacingldefibrillator leads into the cardiac 
chambers(l). 
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1.3 Anatomy of the atrial switch operation. 
Dextro-transposition is incompatible with life because of ventriculo-arterial discordance. The 
systemic venous blood from the superior and inferior vena cavae drain into the right atrium 
(RA), through the tricuspid valve and is ejected into the aorta. The pulmonary veins drain into 
the left atrium and then sub-pulmonary left ventricle (pL V) through the mitral valve and 
empty into the pulmonary artery. There is invariably mixing at atrial level enhanced by 
presence of a patent ductus arteriosus ct/3 of patients) or a ventricular septal defect 
el3 of patients). A complex transposition refers to the co-existence of either a ventricular-
septal defect or sub-pulmonary stenosis in contrast to a simple transposition where there is no 
haemodynamically significant concomitant lesion(6). 
In d-TGA, an atrial septostomy is often employed as a palliative procedure until definitive 
correction. The latter previously involved atrial redirection of blood flow utilising a either 
dacron or pericardial patch in the Mustard operation or just atrial tissue in the technically 
more difficult Senning operation(7). These procedures created a revolution in the 
management of d-TGA increasing patient survival to adulthood. The atrium is essentially 
divided into an anterior and posterior compartment separating the passage of systemic venous 
return to the pLY and oxygenated pulmonary flow to the sRV. 
1.4 The coronary venous anatomy in relation to transposition. 
The coronary sinus (CS) in d-TGA, as in the normal human heart, lies in the atrio-ventricular 
groove between the left atrium and left ventricle. In the case of surgically altered d-TGA, the 
resultant sRV, is therefore not encircled by the CS. This limits transvenous access to the 
lateral wall of the sRV, for lead placement. A large aberrant coronary vein arising from the 
sRV may drain into the CS or directly into the RA. This may present an option for lead 
placement. An anterolateral cardiac vein may be regarded as a poor pacing site for a failing 
systemic LV but may be entirely suitable for pacing the sRV. In an anatomical study by 
Uemura et aI, in hearts with congenitally corrected transposition (atrio-ventricular and 
ventriculo-arterial discordance), the CS drained the sRV in the majority (87%) of specimens 
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with 5 having partiaV complete drainage directly into the atrium(8). Access to the coronary 
venous vasculature post Mustard surgery in d-TGA is also depend on whether the surgeon 
leaves the CS os open to the systemic-atrial side of the baffle or to the pulmonary-venous 
portion. The next challenge is being able to cannulate the CS percutaneously given the altered 
atrial structure. Direct imagining using cardiac magnetic resonance imaging, computerized 
tomography, intracardiac or transoesophageal echocardiograpy improves identification of 
coronary venous anatomy(9-11). These, however, depend on local expertise, availability and 
cost considerations. They were not employed in this cohort. 
1.5 The implantable cardioverter-defibrillator 
The concept of an implantable defibrillator, the size of a pacemaker, is attributed to Michel 
Mirowski in the 1960's which later, in collaboration with Morton Mower, lead to animal 
experimentation in the 1970's and the first human studies in 1980(8;12). 
The lCD, in essence, consists of a capacitor which stores and then dissipates the charge, a 
battery and a processing unit. The size of the ICD is mainly dependent on the former two 
components and with current technology this has been reduced to 35 cm3 allowing for pre-
pectoral implantation performed under conscious sedation just like a pacemaker(13). Initial 
implants utilised epicardial patch electrodes with a surgical implantation of the ICD into an 
abdominal location, however development of a coil electrode mounted around the lead, 
allowed for transvenous implantation to the endocardial surface of the RV(14). Implantable 
cardioverter-defibrillators now also incorporate brady- and antitachycardia pacing in addition 
to defibrillation functions. Sophisticated algorithms have also evolved to limit the occurrence 
of inappropriate therapies, in the hope of achieving painless resolution ofVT and to conserve 
battery life. The latter still remains limited tojust 4-5 years relative to 7-10 years achieved by 
modem pacemakers and is largely due to the charging of the capacitor in addition to 
supporting complex circuitry and pacemaker functions(15;16). 
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1.6 Defibrination concepts 
Our understanding of the mechanisms of ventricular fibrillation(VF) have evolved from a 
simplistic view of random chaotic electrical activity to a more structured re-entry mechanism 
consisting of self replicating rotors( 17). The origin of each rotor may depend on the 
underlying myocardial substrate( 18). Initiation may be spontaneous (as in a clinical setting) or 
induced by high frequency burst pacing (typically 50 or 60Hz), direct current application 
across cardiac tissue, or by a low voltage shock delivered during the vulnerable repolarization 
phase. 
Effective arrest ofVF in a clinical setting, is the challenge to current medical technology. It 
relies on a discharge of electrical energy from the defibrillator applied across 
epicardial/endocardial/subcutaneous electrodes. These pulses of energy are delivered as two 
components with the highest voltage in the leading edge and typically decays to a pre-defined 
limit (usually 50 or 60%). The polarity of the pulse is then reversed and it continues to decay 
to completion( figure 1.1). The duration of each pulse, referred to as the pulse width, is a 
reflection of capacitance and influences efficacy( 19). This dual component waveform is 
described as biphasic. It has been shown in studies to be superior to monophasic and even 
triphasic patterns and is the standard in current commercially available IeDs although 
variation exists between manufacturers for nominal settings(20). 
The energy required to defibrillate is subject to characteristics of both the substrate and device 
components. A high body mass index and ventricular hypertrophyl dilation has been shown to 
reduce defibrillation efficacy. Also, the longer the duration ofVF, the more difficult it 
becomes to effect defibrillation, emphasising the need for shorter capacitor charge times and 
for initial device therapies to be effective(l9;2l;22). 
The implanted defibrillator system can be adapted to overcome these limitations to some 
extent. Increased electrode width and surface area improves defibrillation thresholds (DFTs). 
So the addition of adjunctive subcutaneous, epicardial or transvenous leads may be used to 
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enhance efficacy in a clinical setting(23). The position of electrodes, particularly in an 
endocardial system, may alter the path of current or improve the contact with the ventricular 
surface. The ventricular septum represents the largest myocardial bulk and therefore it 
necessary to maintain this cardiac tissue juxtaposed within the path ofthe defibrillation 
current(24). 
Reversal of the polarity of the first phase may, also improve defibrillation outcome, therefore 
the leD is programmed to automatically reverse the polarity of the shock waveform after 
several failures (25). 
The use of a high energy device (maximum 4lJ available commercially) may also be used to 
achieve successful defibrillation although this measure increases cost particularly if 
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1.7 Evolving concepts of cardiac resynchronization therapy 
Cardiac resychronization therapy (CRT) has become an integral part of the management of 
patients with ischaemic and non-ischaemic cardiomyopathies presenting with advanced heart 
failure. It not only forms a bridge to transplantation and an effective measure to improve 
functional status but positively influences ventricular remodelling translated into decrease of 
cardiac dimensions, increased EF and reduced mortality(26). This device based strategy has 
also been successfully applied in patients with adult congenital heart disease and ventricular 
dysfunction(27). Experience is however limited in patients with morphological sRV s and 
selection criteria are being defined in the face of the expanding application ofCRT(28;29). 
Cardiac asynchrony has been traditionally defined in patients in terms of electrical 
(QRS width> 120ms) and doppler echocardiography (conventional/ tissue doppler). The CRT 
non-responder population however remains between 20-30% warranting evaluation of 
additional or alternative measurements(30). 
Electrical stimulation of the failing systemic ventricle is usually achieved transvenously via 
CS cannulation, utilising specially designed left venticular pacing leads. If this is unsuccessful 
(eg. lack of a suitable ventricular vein) a trans-sternal, surgical approach may be used. The 
latter ,however, may be preferable if conducted at the time of cardiac surgery or with 
surgically/ congenitally altered anatomy that makes transvenous CS access difficult or 
unachievable. 
1.8 Three dimensional (non-contact) electro physiological mapping 
The non-contact multi-electrode array (MEA) system (Ensite3000. St. Jude Medical, USA) 
consists of 64 electrode wires woven in a basket conformation around a balloon (figure 1.2). 
It is deployed in a collapsed state into the chamber to be evaluated. In this study, the MEA 
was advanced over a 0.032in J-tipped wired trans-aortic ally and retrogradely over the aortic 
valve into the sRV. The balloon was then inflated with a contrast-saline solution to a volume 
where the electrodes lay in close proximity but not touching the endocardium. 
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Acquisition of far field electrograms are amplified by system, and generate up to 3360 virtual 
electrograms across the endocardium of the sampled cardiac chamber. This method then, uses 
inverse mathematical formulae, in order to generate dynamic voltage maps of the 
endocardium in sinus rhythm and arrhythmia. Static maps are also possible by generating a 
colour representation of the temporal sequence of activation of the endocardium as well as the 
location of scar tissue derived from measured voltage gradients. The sampling is 
instantaneous and intuitive in that it is presented in a three dimensional recreation of the 
cardiac chamber(31 ;32). 
Apart from its validation in mapping of re-entry and focal/automatic arrhythmias. Lambiase et 
al. have demonstrated its use in defining areas of slow electrical conduction, thus guiding 
CRT to more optimal sites for "LV" lead placement(33). 
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2 Study Design 
2.1 Ethical considerations 
All patients where jointly managed at a tertiary referral centre for clinical electrophysiology 
and adult congenital heart disease in the United Kingdom. Infonned consent was obtained 
from each patient included in this study. Fonnal ethical approval for this descriptive, 
prospective investigational study was not required as all patients had severe debilitating heart 
failure symptoms and! or risk of SCD. Conventional management would have entailed 
inevitable cardiac transplantation, its associated complications and limited longevity. The 
decision to resort to device therapy was therefore taken out of clinical and life-saving 
necessity and was conducted in tenns of our current understanding of best clinical practice. 
Where innovative strategies were employed, this was used primarily to increase patient 
benefit from a more refined and patient-tailored technique. 
2.2 Statistical analysis 
The studies mentioned make use of standard descriptive biographical data captured using 
Excel (Microsoft™) and where necessary tests of significance were conducted using SPSSTM. 
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3. Cardiac defibrillator therapy for at risk patients with failing systemic right 
ventricles. 
3.1 Introduction 
Patients post Mustard correction have been demonstrated to be at increased risk of SCD 
proportional to the degree of sRV dysfunction as well the presence of atrial arrhythmias (34). 
In other populations recognised to be at high risk of SCD, it is well recognised that ICD 
therapy is a highly effective, and arguably the only effective treatment modality(35;36). 
Given the particular anatomy after a Mustard procedure, problems with transvenous access to 
the pL V and altered vectors of defibrillation, it cannot be assumed that the general efficacy of 
ICDs will be reproduced in these individuals. In order to describe the technical considerations 
involved, a single centre experience ofICD therapy in 5 consecutive patients with a Mustard 
procedure for d-TGA considered to be at high risk of SCD was reviewed. 
3.2 Methods: 
A prospective evaluation was conducted of the technical considerations, implant details, and 
follow-up on 5 patients with d-TGA and a Mustard procedure receiving an ICD ± 
concomitant CRT. Functional status, arrhythmia history and echocardiographic data before 
implant were reviewed. Right ventricular function was assessed by a single experienced 
operator combining echocardiographic visual appraisal and planimetry as well as RV 
angiography. An individualized approach to implantation was undertaken, taking into 
consideration existing transvenous electrodes and post surgical cardiac anatomy. Following 
implantation, patients were followed-up at 4-6 weeks and then 6-monthly intervals. Data at 




The baseline characteristics of the 5 patients (4 male, age 18-35 years) studied are shown in 
figure 3.1. All had significantly impaired sRV function {mean sRV EF=30%} and impaired 
functional class (NYHA class II-lin. Two patients had sustained VT, 3 non-sustained VT, 
and 4 had atrial arrhythmias. Four patients had previously implanted pacemakers. Pre-implant 
electrophysioiogicai studies were not performed. 
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The role of polarity reversal is less well established. Data from randomised trials provides 
some evidence but no rational explanation, that by inverting vectors, efficacy may be 
improved in patients(40). However, with a limited number of inductions in any given 
individual, apparent differences in efficacy may be no more than a reflection of the 
probabilistic nature of defibrillation success and we need to be cautious in making finite 
decisions as regards what will and will not work in individual patients. 
The single patient experience with subcutaneous defibrillation was plainly suboptimal with no 
successful defibrillation achieved. This may be a reflection of the Mustard anatomy or other 
independent factors that potentially may affect defibrillation efficacy. This patient had a body 
mass index of 33 and gross cardiomegaly(21). 
Cardiac resynchronisation in this group was performed as an adjunct to ICD implantation and 
presented its own challenges eventually requiring a hybrid approach in 2 patients with 
endocardiaVepicardial systems and is covered in the next chapter. 
The central issue explored in this report is how to manage this population at increased risk of 
SCD with particular challenges to effective defibrillator implantation. Our experience 
demonstrates that transvenous implantation is feasible but may require interventions such as 
lead extraction and angioplasty of the atrial baffle to avoid venous pathway obstruction. The 
optimal defibrillation vector with a transvenous implant appears to be pL V to active can and 
as such, single coil leads are preferred. Our experience with subcutaneous arrays alone was 
unsatisfactory. Efficacy may be improved by selecting patients with a smaller body habitus 
and by incorporating intra-thoracic electrodes. Epicardial patches require an open chest 
procedure and may be placed at the time of concomitant epicardial CRT if indicated in the 
individual patient. 
Our findings mandate the use of high output devices, regardless of the configuration, in 
anticipation of compromised defibrillation efficacy in similar patients which ultimately may 
prove more cost effective than undertaking revision procedures. 
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The patient that underwent a prolonged procedure prior to OFT testing resulting in post-
procedural pulmonary oedema, emphasised the inability of the compromised myocardium to 
sustain stresses. We therefore now undertake a staged approach to the ICD implantation, 
deferring defibrillation testing to another session if the implant procedure was prolonged or 
complicated. This practice however increases the probability of re-intervention if a suitable 
defibrillation safety margin is not attained. 
3.5 Limitations: 
This is a descriptive report on a small cohort and as such does not provide sufficient 
quantitative data. Given the low likelihood of a randomised trial, multi-centre, pooled, 
observational data is necessary to obtain a greater understanding of device therapy in this 
popUlation. 
3.6 Conclusion: 
Defibrillator implantation in Mustard patients is feasible though challenging. Clinicians 
planning to implant such patients must be prepared to optimise the systemic venous access of 
the baffle prior to implantation and then to have strategies in place to tackle high defibrillation 
thresholds and the decompensation that may result from multiple VF inductions. Endocardial 
pLY to active can and epicardial patches are effective defibrillation strategies in this group. 
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4. A hybrid form of cardiac resynchronisation therapy in patients yielding 
contrasting results. 
4.1 Introduction 
Although the atrial switch was abandoned in the 1980s for the Jatene (arterial switch) 
procedure, a considerable number of patients have survived into their third decade of life( 41). 
The right ventricle is not capable of supporting the systemic circulation for this extended 
period. Patients post Senning or Mustard operations, invariably experience right ventricular 
failure by the second and third decades of life( 4;42). If cardiac transplantation is their only 
option, these patients face a post operative average life expectancy of just 10 years(43). 
Coupled with the limited availability of donors, this management plan is suboptimal for these, 
generally young patients. Cardiac resynchronisation therapy combined with defibrillation 
(CRTID) has impacted on both quality and quantity of life in patients with severe ventricular 
dysfunction (44). The application of device therapy to patients with RV failure provides an 
attractive option. I present here 2 cases who had pre-existing dual chamber pacemakers 
upgraded to CRTID, using epicardial leads implanted by surgical thoracotomy. Although the 
results varied for both cases, they demonstrate a plausible alternative to management. 
4.2 Case presentations 
4.2.1 Case 1 
Patient 1 was 110 kg and 22 years old at time of implantation of his CRTID system (figure 
4.1). The underlying congenital anomaly of simple transposition was initially temporised by 
an atrial septostomy soon after birth and then with a Mustard operation at 7 months of age. At 
18 years of age he presented with sino-atrial node dysfunction (a common complication 
following Mustard surgery) and therefore received a dual chamber pacemaker (Medtronic 
THERA DR 7968i. Medtronic. Inc., MA). Transthoracic echocardiogram revealed a dilated 
and myopathic sRV with an EF of25% and a dp/dt ratio = 438.3 with evidence of 
asychronous ventricular contraction. The systemic ventricle (sRV) myocardial performance 
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index was 0.53. An exercise treadmill test showed a suboptimal response in the cardiac output 
of 3.9 Vmin pre-exercise to 9.0 Vmin at maximal exercise. He had underlying right bundle 
branch block QRS morphology. Recent evidence from other series also suggest an increase 
risk ofVTNF and SCD in patients following Mustard procedures presenting with sRV 
dysfunction and atrial tachyarrhythmias( 1). Cardiac resynchronization and defibrillator 
therapy offered a plausible alternative to delaying cardiac transplantation. The implant was 
performed via a mini-thoracotomy through the lower part ofthe previous sternal incision. The 
chronic atrial and pL V leads were conserved and a steroid eluting pace/sense electrode was 
sutured to the inferior epicardial surface of the right ventricle (Medtronic 4968). Two single-
finger subcutaneous defibrillator arrays (Medtronic 6996) were implanted in an antero-
posterior configuration and connected to the defibrillator ports of a Contak RENEWAL 4HE 
defibrillator (Guidant Inc.). Attempts at biventricular pacing (BVP) were also oflimited 
benefit. A TIE guided optimization of CRT resulted in the sRV being paced 40ms before the 
pL V. The paced QRS remained predominantly right bundle branch block in morphology but 
had increased to 200ms from a baseline width of l20ms. Apart from not experiencing a 
subjective improvement in symptoms, the patient presented with episodes of recurrent 
paroxysmal atrial flutter documented on holter analysis. 
A successful flutter ablation was performed using non-contact mapping (Ensite™. St. Jude 
Medical). Two lines of block were created extending from the inferior vena cava to the 
inferior limb of the baffle and also from the tricuspid valve to the pulmonary venous side of 
the baffle. Despite further adjustment to the paced atrioventricular (AVD) and ventricular off-
set, there was no improvement in symptoms. At his most recent follow-up doppler parameters 
suggested atrial pacing provided the optimal configuration (AAIR). 
His effort tolerance was quantified objectively on the treadmill using the Bruce protocol and 
he exercised for 6.58 minutes. He is currently being managed medically. 
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Cardiac resynchronization therapy has dramatically improved the quality of life in patients 
presenting with grade III and N NYHA symptoms of heart failure(44). I have demonstrated 
its application in two patients with sRV dysfunction using surgically positioned epicardial 
leads. 
It may be argued that preceding angioplasty of significant baffle related stenoses in both 
patients may have contributed to functional improvement in at least I of the patients. The 
baffle angioplasties were performed in both patients as a separate procedure at least 48 hours 
before device implantation. This was done primarily to reduce the duration of the device 
implantation procedure but neither patient demonstrated appreciable clinical or 
echocardiographic benefit from relief of the stenoses on myocardial function in the period 
leading up to the actual implant. 
The RV in a normal heart is a thinner walled and crescent shaped structure, that is not a 
suitable long term substitute for the left ventricle. The concave intrusion of the septum into 
the cavity of the RV also provides the optimal geometry for overall RV function(45). Ifleft to 
chronically support the systemic circulation, the RV hypertrophies and dilates with 
subsequent flattening of the interventricular septum. The resultant dyskinetic septal motion 
further worsens the functional impairment of the dysfunctional RV. Resynchronization 
therapy should therefore serve not only to pace the RV free wall but co-ordinate this with 
septal motion. This complex anatomical and functional interaction suggests that we need to 
take greater care in positioning pacing leads over the sRV, to ensure adequate septal and free 
wall recruitment during biventricular pacing. 
From this discussion we can infer why CRT failed in the first patient. The epicardial lead was 
placed on the sRV at the discretion of the surgeon over its inferior border with no formal 
guidance. It was only limited by the pacing threshold at the respective site. This arbitrary 
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placement may have been responsible for the non-response. Perhaps a more guided approach 
such as that suggested by Dekker et al using intra-procedural pressure-volume loop 
monitoring may have altered the outcome( 46). 
Epicardial pacing systems have been more frequently associated, than transvenous systems, 
with higher pacing thresholds, diaphragmatic stimulation, lead fracture and insulation 
breaks(47).The use of steroid eluting leads, does alleviate some of the deterioration in pacing 
parameters but this unfortunately did not offer an advantage in the second patient(48). Due to 
previous surgery, the location of viable myocardium for pacing is difficult and placement of 
electrodes on the inferior aspect of both the sRV s was partially because of the ease of access 
to this area. This, however is more likely to increase the incidence of diaphragmatic pacing 
given its proximity and also does not truly pace the area of maximum mechanical delay 
The role of an epicardial pacing strategy in CRT should however should not be 
underestimated. Transvenous attempts at coronary sinus cannulation have often resulted in 
failures and surgical epicardial lead placement is resorted to or this approach can be a primary 
strategy especially in patients like ours because of the complex anatomy. Mair et al in a 
comparative study, also demonstrated a higher complication rate with transvenous CS lead 
placement than with epicardial implantation via a mini-thoracotomy procedure(47). I am not 
advocating that epicardial pacing is the favoured approach in these patients, but rather wish to 
emphasise it as a potentially advantageous strategy particularly if combined with video-
assisted thorascopy creating a minimally invasive percutaneous approach(49). 
Another explanation for the poor clinical response in the first patient, could be due to 
inappropriate device programming. Despite a TTE guided programming ofthe A VD and 
ventricular offset, the QRS width increased by 80ms during BVP. The use of standard 
spectral doppler to optimise pacing seems incongruous as there is as yet, no defined 
parameters of asynchrony evaluated for patients with sRV dysfunction nor for that matter, 
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generally in patients with underlying congenital cardiac disease. So the criteria to re-establish 
synchrony are thus dubious. It could mean that tissue doppler segmental analysis and three 
dimensional reconstruction are more sensitive models to use in this context(50). 
Nevertheless, failure of epicardial pacing in both these patients did warrant evaluating a 
transvenous implantation strategy in patients with d-TGA after atrial switch. surgery. In their 
attempt at transvenous atrial pacing in patients presenting with sino-atrial node dysfunction 
following a Fontan procedure, Hansky et aI, chose to detail the anatomy preoperatively with 
cardiac magnetic resonance imaging as well as angiographically( 51). A similar strategy 
should be undertaken in patients following a Mustard or Senning procedure preceding 
transvenous device implantation. Stenosis of the superior limb of the baffle and superior vena 
cava has been mentioned in the literature and the incidence is higher following a Mustard 
operation than with the Senning procedure(7;49). None of our patients had magnetic 
resonance imaging because of cost as well as because of pre-existing pacemakers but detailed 
TIE and pre-operative angiography was performed to assess ventricular function and the 
patency of the atrial baffles. The presence of a dual chamber pacemaker leads would have 
made venous cannulation difficult because of limited space within the baffle, so epicardial 
lead implantation and conservation of the existing endocardial leads seemed sensible. 
The feasibility and safety of endocardial pacing of the systemic ventricle using a transseptal 
route to the left ventricle in normally "transposed" hearts was shown by Jais et al in a small 
series of 11 patients(52). In patients post Mustard correction, this would mean perforation 
through the atrial baffle or passage through a baffle leak to implant the lead onto the 
endocardial surface of the sRV followed by life long anticoagulation because of the potential 
for paradoxical and systemic embolization. Disruption to the atrial structures and interference 
with the atrioventricular valve may become issues in the long term follow-up of these patients 
but this remains an option with the benefit of more stable endocardial pacing thresholds. I will 
explore this concept in the next chapter. 
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4.4 Conclusion 
The application of CRT to patients following an atrial switch procedure with failing sRVs is a 
feasible alternative to delaying cardiac transplantation. I have presented 2 cases in whom an 
upgrade from dual chamber pacing to BVP was attempted using epicardial leads and by 
conserving the chronic endocardial electrodes. The limited success rate is not a deterrent for 
further evaluation but shows the need for refinement of this hybrid strategy. 
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5. A novel approach to cardiac resynchronisation therapy for a failing systemic right 
ventricle. 
5.1 Introduction 
Progressive sRV dysftmction, atrial and ventricular arrhythmias and SCD are well-
recognized late sequelae of atrial redirection surgery(2). Although cardiac 
resynchronisation therapy poses an attractive therapeutic option, little is known about 
indications, patient selection, and technical aspects of best lead placement. I discussed 
in the previous chapter an attempt at CR TID therapy in 2 patients who bear 
resemblance to the following case. Only 1 of these patients demonstrated clinical 
improvement. These mixed results prompted a more refined strategy to assess 
mechanical and electrical ventricular asynchrony and to attempt a fully percutaneous 
means of achieving CRT as is illustrated in the following case study. 
5.2 Methods 
A 27 year old female with a Mustard procedure for d-TGA, and subsequent DDDR 
pacemaker implantation for sinus node dysfunction at age 17years, presented with progressive 
effort intolerance. Transthoracic echocardiogram and angiography revealed a dilated sRV 
with systolic dysfunction (EF=23%) and predominant lateral free wall hypokinesia. 
Holter monitoring revealed episodes of non-sustained ventricular tachycardia. The 12-lead 
electrocardiogram (ECG) revealed atrial and ventricular sequential pacing with fused 
sinus/paced QRS complexes measuring nOms. She achieved just 4.8 minutes on treadmill 
testing (Bruce protocol) compared to just 8.4 minutes documented 10 years earlier. 
Preceding diagnostic cardiac catheterization revealed severe stenosis of the inferior baffle and 
a minor leak in the superior baffle communicating with the pulmonary venous atrium. Stent 
angioplasty of the inferior baffle was performed to relieve the obstruction (figure 5.1). 
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5.3 Results 
Despite the shortest activation time of 90ms occurring with AAI pacing, the maximal acute, 
blood pressure response of 73mmHg( average 60±9 mmHg) occurred during BVP 
(figure 5.6). An early (1 week TIE) and sustained (after 6 months) 43% improvement in EF 
was also noted (23% to 33%). Effort tolerance improved from NYHA III to II accompanied 
by a decrease in QR8 width from 130 to 120ms during consistent synchronous BVP in DDDR 
mode .No antitachycardia therapies have thus far been documented. 
5.4 Discussion 
We have presented here a novel strategy using ventricular activation maps to direct 
endocardial lead placement in an effort to achieve successful BVP in patients with a Mustard 
procedure and a failing sRV. The application of CRT has been extrapolated to the adult 
congenital heart disease population following success in treating patients with 
cardiomyopathies. Although no randomised controlled data exists for these patients, there has 
been documentation in the form of small case series(53;27). What is apparent is that 
conventional selection criteria may not apply and that there is variation in technical 
approaches sometimes requiring a combined endocardial and epicardial system. 
Conventional CRT has a non-responder rate of between 20-30%(50). This could potentially 
be higher in this exclusive group and hence the need for a more rigorous selection process. 
Non-contact mapping has been used to defme areas of slow conduction guiding left 
ventricular pacing in cardiomyopathies (33). The MEA catheter (Ensite™. 8t. Jude Medical) 
was easily deployed into the sRV in our patient under anticoagulation. The late and possible 
non-activation of the sRV lateral wall during pL V pacing was made apparent by this three 
dimensional electrical mapping technique. 
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This correlated with mechanical evidence of severe hypokinesia in these segments on TIE. 
This observation suggests that pacing from the apex of the pL V not only results in delayed 
and asynchronous sRV activation, but may worsen sRV dysfunction - a phenomenon 
previously described in the non-paced ventricle(54). 
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The acute haemodynamic response during pacing is well documented and correlates with 
optimal pacing selection(55;56). The blood pressure response was used as a surrogate marker 
for the cardiac output during the implant procedure. This proved effective, fast and clinically 
relevant evidenced by a significant mean blood pressure rise of 18mmHg during BVP as 
opposed to DDD pacing (p=O.OOI). The baffie leak: provided a portal of access to the sRV 
without causing disruption to baffie integrity. An epicardial position may have provided 
similar benefit but the equipment and expertise is currently not available to do this as a 
minimally invasive procedure at this unit. However, the sheathed delivery system used 
allowed the operator manoeuvrability within the sRV. The narrow diameter of the lead also 
helped minimise obstruction to the conduit and systemic atrioventricular valve function. 
However, the favourable lead profile does not reduce the risk of thrombo-embolism and the 
patient has therefore been anti-coagulated with warfarin. 
5.5 Conclusion 
Given the relative ease of accomplishing CRT guided by NCM and intra-procedural 
hemodynamic monitoring, we propose that a prospective evaluation ofthis approach 
is warranted. Long term follow-up is also needed to evaluate if the above strategy 
affords any advantage over current practice and an improvement in the non-responder 
rate. A minimally invasive epicardial lead implantation system, especially ifpossible 
under conscious sedation, has the advantage of access to the sRV without the need for 
anticoagulation and avoids intracardiac lead clutter. Further development is needed. 
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6. Conclusions 
The advent of atrial redirection surgery heralded potential survival to adulthood for patients 
with d-TGA who would have otherwise faced inevitable childhood death. However, the late 
complications arising from this surgery, particularly progressive heart failure and the increase 
risk of SCD remain challenges for management. Technological advancement in tenns of 
device therapy (CRTID) have presented an alternative or bridge to cardiac transplantation in 
these patients. 
The indications and best methods to effect successful CRTID therapy however remain 
unknown apart from combined anecdotal evidence. In this patient cohort, the pL V to can 
defibrillation vector remained the most successful as was the use of epicardial patches. An 
exclusively transthoracic system utilizing subcutaneous electrodes proved unreliable because 
ofthe influence of weight in adult patients. A combination of intra cardiac, intra-thoracic and 
subcutaneous electrodes is however sometimes necessary to enhance defibrillation efficacy. 
The initial experience with CRT using a combined endocardial/epicardial lead system proved 
inconsistent and may have been because of poor patient selection but also because of 
suboptimal epicardial lead placement. The use ofNCM in addition to echocardiographic 
criteria was used to define asynchrony and guide endocardial placement of a pacing lead 
within the sR V. This warranted anticoagulation, but was perfonned with relative ease as a 
transvenous procedure under conscious sedation demonstrating its potential sustainability. 
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7. Future directions 
The ideas proposed by this dissertation may help clinicians faced with the management of 
similar, challenging patients. It is a chronological and evolutionary account of management 
strategies undertaken at a single tertiary level institution. It is unlikely that there will ever be a 
randomized controlled trial because of limited patient numbers and the highly varied patient 
characteristics requiring an individualized approach. This study does however emphasize the 
need for more data and technological advancement in order to assist management. 
The limitations of current lead development and energy capabilities of modem ICDs are 
evident from failed endocardial and transthoracic defibrillation attempts. A more efficient 
minimally invasive mechanism is also needed for epicardial lead placement, in order to 
achieve CRT using this approach. Recent advances have expanded the use of tissue Doppler 
and three dimensional echocardiography ventricular asynchrony(57). Other imaging 
technologies that are being investigated or show potential for application in this sphere 
include intracardiac and trans oesophageal echocardiography, multi-slice computerized 
tomography, magnetic resonance imaging and nuclear scintigraphy (9; 1 0;21 ;58-59). The use 
ofNCM to aid CRT is innovative and reveals the need for a more defined understanding of 
asynchrony in patients with congenital heart disease. These topics warrant further research. 
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